Overview
Acellular dermabrasion (ADA) and Acellular Stimulating Laser Ablation (ASL) are major cosmetic surgery options for improving the look of the breasts and are considered very effective when used in conjunction with mammoplasty. Acellular dermabrasion is a technique, which involves a medical laser or infra-red laser being applied to a large area of the skin or fat. The fat or subcutaneous tissue is “smashed” and the exposed underlying muscle and underlying structure are markedly improved. Once the fat or subcutaneous tissue has been improved, it is generally repositioned using an instrument such as a tumescent needle. In the early stages of the development of the breast, the acellular dermal matrices may be used to treat a wide variety of local problems. They are particularly successful in treating a variety of skin irregularities.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4442
Market Dynamics
Increasing prevalence of breast cancer in the women population is expected to drive growth of the U.S. acellular dermal matrices market during the forecast period. According to the American Cancer Society, in 2021, around 281,550 new cases of invasive breast cancer are expected to be diagnosed in women across the U.S., while around 43,600 women will die from the same. According to the same source, around 1 in 8 U.S. women will develop invasive breast cancer over the course of their lifetime. Acellular dermal matrix is a soft connective tissue graft generated via a decellularization process. It typically preserves the intact extracellular skin matrix. ADM is widely used in breast surgery for reconstruction to support implants. Hence, such factors are expected to drive market growth in the near future.
However, product recalls and complications associated with ADM in breast surgery are expected to hinder the U.S. acellular dermal matrices market growth over the forecast period.
Impact of COVID-19 Pandemic
Since the outbreak of the COVID-19 pandemic, many industries have been witnessed significantly across the globe, including the U.S. acellular dermal matrices market. According to the World Health Organization (WHO), as of October 2021, over 44 million cases of COVID-19 were reported with over 724,605 deaths across the U.S. The U.S. government implemented stringent lockdown policies, which led to a major disruption in the global supply chain industry, rendering a sharp decline in economic activities. However, the market is expected to regain its lost traction with the rollout of vaccines and relaxation in the regulations.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4442
Key Takeaways
-
The U.S. acellular dermal matrices market is expected to witness significant growth, registering a CAGR of 10.6% over the forecast period. This is owing to increasing product launches by key companies in the market. For instance, in August 2021, AlloSource AlloMend Ultra-thick Acellular Dermal Matrix (ADM).
-
On the basis of application, the reconstruction procedures segment accounted for the largest share in the U.S. acellular dermal matrices market. This is owing to growing launches of novel products by key companies across the country.
-
Key companies involved in the U.S. acellular dermal matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis Limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4442
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Origin
- Market Snapshot, By Application
- Market Snapshot, By Place of Setting
- Coherent Market Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Key Developments
- Technological Advancement
- New Product Launch/Approvals
- Acquisition, Collaboration & Agreements
- Market Share Analysis
- Brand Analysis
- Market Dynamics
- U.S. Acellular Dermal Matrices Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact on Supply and Demand
- Impact on Procedures
- Government Initiatives
- U.S. Acellular Dermal Matrices Market, By Origin, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Human Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Porcine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Bovine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Introduction
- U.S. Acellular Dermal Matrices Market, By Application, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Burns
- Trauma
- Cancers
- Infections
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcer
- Others
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Reconstruction Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Abdominal Wall Procedures
- Breast Procedures
- Orthopedic Procedures
- Others
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
- Introduction
- U.S. Acellular Dermal Matrices Market, By Place of Setting, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Office Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837